Aziz Mottiwala Tarsus Pharmaceuticals, Inc. (TARS) insider trading activity

Aziz Mottiwala is Chief Commercial Officer of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 65,057 shares of TARS, which is worth approximately $3.25 Million. The most recent transaction as insider was on Mar 20, 2025, when has been sold 3,365 shares (Common Stock) at a price of $50.11 per share, resulting in proceeds of $168,620. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 65.1K

20.31% 3M change

20.31% 12M change

Total Value Held $3.25 Million

Aziz Mottiwala Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 20 2025	SELL Open market or private sale	$168,620 $50.11 p/Share	3,365 Reduced 4.92%	65,057 Common Stock
Mar 19 2025	SELL Open market or private sale	$168,601 $47.4 p/Share	3,557 Reduced 4.94%	68,422 Common Stock
Mar 18 2025	SELL Open market or private sale	$168,634 $46.29 p/Share	3,643 Reduced 4.82%	71,979 Common Stock
Mar 15 2025	BUY Exercise of conversion of derivative security	-	20,957 Added 21.7%	75,622 Common Stock
Mar 18 2024	SELL Open market or private sale	$145,839 $30.6 p/Share	4,766 Reduced 8.1%	54,075 Common Stock
Mar 15 2024	BUY Exercise of conversion of derivative security	-	12,938 Added 18.02%	58,841 Common Stock
Jul 19 2023	SELL Open market or private sale	$48,120 $20.05 p/Share	2,400 Reduced 4.98%	45,806 Common Stock
Jun 08 2023	SELL Open market or private sale	$2,000 $20.0 p/Share	100 Reduced 0.21%	48,086 Common Stock
Jun 07 2023	SELL Open market or private sale	$48,350 $19.34 p/Share	2,500 Reduced 4.93%	48,186 Common Stock
Jun 06 2023	SELL Open market or private sale	$39,881 $18.61 p/Share	2,143 Reduced 4.06%	50,686 Common Stock
Mar 23 2023	SELL Open market or private sale	$4,519 $12.15 p/Share	372 Reduced 0.7%	52,829 Common Stock
Mar 22 2023	SELL Open market or private sale	$4,512 $12.64 p/Share	357 Reduced 0.67%	53,201 Common Stock
Mar 21 2023	SELL Open market or private sale	$4,498 $12.89 p/Share	349 Reduced 0.65%	53,558 Common Stock
Mar 20 2023	SELL Open market or private sale	$4,514 $12.61 p/Share	358 Reduced 0.66%	53,907 Common Stock
Mar 17 2023	SELL Open market or private sale	$4,501 $13.28 p/Share	339 Reduced 0.62%	54,265 Common Stock
Mar 16 2023	SELL Open market or private sale	$4,512 $13.43 p/Share	336 Reduced 0.61%	54,604 Common Stock
Mar 15 2023	BUY Exercise of conversion of derivative security	-	4,790 Added 8.02%	54,940 Common Stock
Nov 15 2022	SELL Open market or private sale	$121,506 $17.72 p/Share	6,857 Reduced 12.12%	49,729 Common Stock
Aug 24 2022	BUY Exercise of conversion of derivative security	$29,675 $5.72 p/Share	5,188 Added 8.4%	56,586 Common Stock
Nov 08 2021	SELL Open market or private sale	$53,100 $28.11 p/Share	1,889 Reduced 3.63%	50,203 Common Stock
Nov 05 2021	SELL Open market or private sale	$309 $28.11 p/Share	11 Reduced 0.02%	52,092 Common Stock
Nov 04 2021	SELL Open market or private sale	$2,803 $28.03 p/Share	100 Reduced 0.19%	52,103 Common Stock
Nov 02 2021	SELL Open market or private sale	$161,460 $26.91 p/Share	6,000 Reduced 10.31%	52,203 Common Stock
Sep 10 2021	SELL Open market or private sale	$57,435 $22.15 p/Share	2,593 Reduced 4.27%	58,203 Common Stock
Sep 10 2021	BUY Exercise of conversion of derivative security	$39,714 $5.72 p/Share	6,943 Added 10.25%	60,796 Common Stock

Aziz Mottiwala

Chief Commercial Officer

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TARS shares.

Notify only if

Value

Insider Trading

Get notified when an Tarsus Pharmaceuticals, Inc. insider buys or sells TARS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Tarsus Pharmaceuticals, Inc.

Track Activities on TARS

Account